Zacks Investment Research on MSN
Cartesian Therapeutics, Inc. (RNAC) upgraded to buy: What does it mean for the stock?
Investors might want to bet on Cartesian Therapeutics, Inc. (RNAC), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...
July 2 (Reuters) - Cartesian Therapeutics (RNAC.O), opens new tab said on Tuesday that its experimental therapy helped reduce symptoms of a rare, immune-related disorder, meeting the main goal in a ...
Automation World's Managing Editor, Wes Iversen talks with Dan Throne, Industry Sector Manager, Bosch Rexroth, about the company's Cartesian Motion System (CMS Robot).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback